• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

MINC Executive Management Team







now that MAG runs the show- worry about those arrogant idiots...ONE Medela and the horrible development teams and everyone working in a vacuum will bring this company to a halt. watch sales go down and the new projects- total mess. they wont be ready for a year at least.